97 related articles for article (PubMed ID: 25081827)
21. Latent transforming growth factor-beta binding protein-1 in circulating plasma as a novel biomarker for early detection of hepatocellular carcinoma.
Cao B; Yang L; Rong W; Feng L; Han N; Zhang K; Cheng S; Wu J; Xiao T; Gao Y
Int J Clin Exp Pathol; 2015; 8(12):16046-54. PubMed ID: 26884881
[TBL] [Abstract][Full Text] [Related]
22. Does surveillance for hepatocellular carcinoma benefit patients with compensated cirrhosis?
Yopp A; Waljee A; Singal AG
Gastroenterology; 2014 Oct; 147(4):935-6. PubMed ID: 25150788
[No Abstract] [Full Text] [Related]
23. Biomarkers for the early diagnosis of bacterial infection and the surveillance of hepatocellular carcinoma in cirrhosis.
Conti F; Dall'Agata M; Gramenzi A; Biselli M
Biomark Med; 2015; 9(12):1343-51. PubMed ID: 26580585
[TBL] [Abstract][Full Text] [Related]
24. Hepatocellular Carcinoma Surveillance Among Cirrhotic Patients With Commercial Health Insurance.
Goldberg DS; Valderrama A; Kamalakar R; Sansgiry SS; Babajanyan S; Lewis JD
J Clin Gastroenterol; 2016 Mar; 50(3):258-65. PubMed ID: 26352107
[TBL] [Abstract][Full Text] [Related]
25. Imaging of hepatocellular carcinoma: current concepts.
Parikh A; Taouli B
Recent Results Cancer Res; 2013; 190():33-55. PubMed ID: 22941012
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness of AFP and ultrasound tests on hepatocellular carcinoma mortality in HCV-infected patients in the USA.
El-Serag HB; Kramer JR; Chen GJ; Duan Z; Richardson PA; Davila JA
Gut; 2011 Jul; 60(7):992-7. PubMed ID: 21257990
[TBL] [Abstract][Full Text] [Related]
27. Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol.
Kim HA; Kim KA; Choi JI; Lee JM; Lee CH; Kang TW; Ku YM; Lee SL; Park YS; Yoon JH; Kim SH; Choi MH
BMC Cancer; 2017 Dec; 17(1):877. PubMed ID: 29268722
[TBL] [Abstract][Full Text] [Related]
28. Hepatocellular Carcinoma Surveillance: An Effective But Complex Process.
Singal AG; Murphy CC
Gastroenterology; 2019 Mar; 156(4):1215. PubMed ID: 30543799
[No Abstract] [Full Text] [Related]
29. Patients' misconceptions about surveillance for hepatocellular carcinoma: Education is needed.
van Meer S; Lieveld FI; van Erpecum KJ
J Hepatol; 2016 Sep; 65(3):653-4. PubMed ID: 27320363
[No Abstract] [Full Text] [Related]
30. [The significance of the determination of AFP-isoform in the early diagnosis of hepatocellular carcinoma].
Ishizuka H; Arakawa Y; Nakano E
Rinsho Byori; 1992 Dec; 40(12):1265-73. PubMed ID: 1284914
[TBL] [Abstract][Full Text] [Related]
31. Hepatocellular Carcinoma Surveillance: Does Alpha-Fetoprotein Have a Role?
Mehta A; Singal AG
Gastroenterology; 2015 Sep; 149(3):816-7. PubMed ID: 26231605
[No Abstract] [Full Text] [Related]
32. Hepatocellular carcinoma tumour markers: current role and expectations.
Rich N; Singal AG
Best Pract Res Clin Gastroenterol; 2014 Oct; 28(5):843-53. PubMed ID: 25260312
[TBL] [Abstract][Full Text] [Related]
33. Early detection of hepatocellular carcinoma in patients with cirrhosis by alphafetoprotein, ultrasound and fine-needle biopsy.
Tremolda F; Benevegnù L; Drago C; Casarin C; Cechetto A; Realdi G; Ruol A
Hepatogastroenterology; 1989 Dec; 36(6):519-21. PubMed ID: 2482242
[TBL] [Abstract][Full Text] [Related]
34. [Serum anti-Ku86: a potential biomarker for early detection of hepatocellular carcinoma].
Chu L; Zhang X; Wang G; Zhou W; Du Z; Liu A; Zhao H
Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):123-7. PubMed ID: 24796461
[TBL] [Abstract][Full Text] [Related]
35. Hepatocellular carcinoma detected by regular surveillance: Does timely confirmation of diagnosis matter?
Yeh JH; Hung CH; Wang JH; Kuo YH; Tai WC; Lu SN
Dig Liver Dis; 2016 Jun; 48(6):661-6. PubMed ID: 26992848
[TBL] [Abstract][Full Text] [Related]
36. Utility and cost-effectiveness of screening for hepatocellular carcinoma in a resource-limited setting.
Eltabbakh M; Zaghla H; Abdel-Razek W; Elshinnawy H; Ezzat S; Gomaa A; Waked I
Med Oncol; 2015 Jan; 32(1):432. PubMed ID: 25502085
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic value of PIVKA-II and alpha-fetoprotein in hepatitis B virus-associated hepatocellular carcinoma.
Seo SI; Kim HS; Kim WJ; Shin WG; Kim DJ; Kim KH; Jang MK; Lee JH; Kim JS; Kim HY; Kim DJ; Lee MS; Park CK
World J Gastroenterol; 2015 Apr; 21(13):3928-35. PubMed ID: 25852278
[TBL] [Abstract][Full Text] [Related]
38. Hepatocellular Carcinoma Surveillance: Moving Forward or Looking in the Rear-View Mirror?
Braillon A
Am J Gastroenterol; 2015 Nov; 110(11):1625. PubMed ID: 26618426
[No Abstract] [Full Text] [Related]
39. Re: indeterminate 1-2 cm nodules found on hepatocellular carcinoma surveillance: biopsy for all, some, or none?
Iavarone M; Sangiovanni A
Hepatology; 2012 Feb; 55(2):651; author reply 652. PubMed ID: 22095753
[No Abstract] [Full Text] [Related]
40. A clinical study of lectin-reactive alpha-fetoprotein as an early indicator of hepatocellular carcinoma in the follow-up of cirrhotic patients.
Shiraki K; Takase K; Tameda Y; Hamada M; Kosaka Y; Nakano T
Hepatology; 1995 Sep; 22(3):802-7. PubMed ID: 7544756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
